
Mariely Hernandez, PhD
Assistant Professor of Clinical Psychiatry
Columbia University Irving Medical Center

ADHD and Substance Use in Women:
Recognition, Risks, and Treatment Considerations
Wednesday, February 10, 2027
8:00 AM - 9:00 AM
Mariely Hernandez, Ph.D. is a licensed clinical psychologist in private practice and maintains a voluntary faculty appointment as an Assistant Professor of Clinical Psychiatry in the Department of Psychiatry at the Columbia University Medical Center. Dr. Hernandez specializes in the diagnosis and treatment of Attention-Deficit/Hyperactivity Disorder (ADHD) and co-occurring conditions (w/special focus on addictions) across the lifespan.
She completed her postdoctoral research training in the Division on Substance Use Disorders at Columbia University Medical Center, under the mentorship of Dr. Frances R. Levin. Alongside her clinical work, Dr. Hernandez is engaged in academic service for educational institutions and non-profit organizations as an invited lecturer and guest speaker for webinars and podcasts. Dr. Hernandez is an active and committed member of the American Professional Society of ADHD and Related Disorders (APSARD), where she’s served as a mentor, co-leader of the ADHD and Substance Use special interest group (SIG), program planning committee member for the annual scientific conferences, and a member of the APSARD US Guidelines for Adult ADHD task force, providing expertise in the screening and diagnosis of ADHD and co-occurring substance use. Currently, Dr. Hernandez is exploring ways to provide psychoeducation about ADHD to broader audiences via social media content creation and collaborations with other experts in the field.
Lecture Summary:
This presentation will examine attention-deficit/hyperactivity disorder (ADHD) in women and its relationship with substance use disorder risk across the lifespan. The session will explore ADHD symptoms that may be overlooked or underrecognized in women, the potential influence of hormonal fluctuations on symptom severity and substance use patterns, and important considerations for treatment and clinical management. The presentation will also address current gaps in the evidence and emerging areas of research that may improve understanding and care for women experiencing ADHD and substance use-related concerns.
Goals and Learning Objectives:
-
Learn how ADHD symptom severity fluctuates in women both across monthly hormone cycles as well as across the lifespan.
-
Identify vulnerable or sensitive periods where women may be at increased risk for hazardous substance use patterns and/or substance use related impairment.
-
Treatment approaches and recommendations for this clinical population.
Disclosures:
This presenter has no relevant disclosures to provide.
.png)